Arsenic early in treatment improves survival for leukemia patients
Thursday, November 11, 2010 - 13:50
in Health & Medicine
Arsenic, a toxic compound with a reputation as a good tool for committing homicide, has a significant positive effect on the survival of patients with acute promyelocytic leukemia (APL), when administered after standard initial treatment, according to a new, multi-center study led by a researcher at Wake Forest University Baptist Medical Center.